Allegheny Financial Group LTD Bluebird Bio, Inc. Transaction History
Allegheny Financial Group LTD
- $397 Million
- Q3 2024
A detailed history of Allegheny Financial Group LTD transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Allegheny Financial Group LTD holds 79,400 shares of BLUE stock, worth $499,426. This represents 0.01% of its overall portfolio holdings.
Number of Shares
79,400
Previous 25,000
217.6%
Holding current value
$499,426
Previous $24,000
70.83%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BLUE
# of Institutions
112Shares Held
61.5MCall Options Held
264KPut Options Held
428K-
Black Rock Inc. New York, NY15.4MShares$97.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$65.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.68MShares$29.5 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$29.4 Million0.02% of portfolio
-
State Street Corp Boston, MA3.84MShares$24.2 Million0.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $485M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...